
Vilya
Developer of a biotechnology platform designed to create medicines that precisely target disease biology. The company's platform builds molecular structures that range in size and antibodies, with cri...
Valuation
$144M
Latest known
Share Price
N/A
Total Raised
$73.8M
Last Round
N/A